Optimus Pharma

Dr. D Srinivasa Reddy, CMD, Optimus Pharma Private Limited, spoke to NDTV today to explain the basics of the recently-cleared Covid pill for India. Molnupiravir has been licensed by US pharma giant Merck for over a dozen Indian firms.

The bulk drugs manufacturer Optimus Pharma is seeking domestic regulatory approval to produce a generic version of Merck & Co's oral COVID-19 treatment molnupiravir, the company's top executive told Reuters on Thursday.

Dr. D Srinivasa Reddy, CMD, Optimus Pharma Private Limited, spoke to NDTV today to explain the basics of the recently-cleared Covid pill for India. Molnupiravir has been licensed by US pharma giant Merck for over a dozen Indian firms.

The bulk drugs manufacturer Optimus Pharma is seeking domestic regulatory approval to produce a generic version of Merck & Co's oral COVID-19 treatment molnupiravir, the company's top executive told Reuters on Thursday.